Goldline Pharmaceutical Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	12.4	7.9	0.54	1.41	0.99
Cash & Short-Term Investments	12.4	7.9	0.54	1.41	0.99
Cash Growth	56.94%	1357.38%	-61.58%	42.44%	-
Accounts Receivable	106.93	96.22	86.27	86.91	84.8
Receivables	129.9	109.84	107.05	86.91	110.04
Inventory	67.77	74.91	53.7	54.61	60.73
Other Current Assets	23.43	2.36	6.94	34.15	-
Total Current Assets	233.5	195	168.23	177.07	171.76
Property, Plant & Equipment	28.37	33.65	24.67	20.96	21.4
Long-Term Investments	-	-	0.34	0.34	3.86
Other Intangible Assets	0.78	0.63	0.58	0.58	0.33
Other Long-Term Assets	0.16	0.07	0.07	3.58	0.34
Total Assets	262.8	229.35	193.88	202.53	197.68
Accounts Payable	20.57	16.44	8.68	15.94	15.61
Accrued Expenses	7.89	6.06	7.69	13.18	12.78
Short-Term Debt	56.5	57.26	49.55	44.22	53.68
Current Portion of Long-Term Debt	21.92	13.52	20.63	-	-
Current Income Taxes Payable	9.91	6.73	1.36	-	-
Other Current Liabilities	0.86	1.65	2.07	1.34	3.43
Total Current Liabilities	117.65	101.66	89.97	74.69	85.5
Long-Term Debt	31.93	40.52	38.11	58.91	44.52
Pension & Post-Retirement Benefits	6.6	5.74	4.61	-	-
Long-Term Deferred Tax Liabilities	0.89	0.56	0.09	-	-
Other Long-Term Liabilities	2.2	2.2	2.2	-	0.02
Total Liabilities	159.27	150.69	134.98	133.59	130.04
Common Stock	69	23	20	20	20
Additional Paid-In Capital	-	-	-	20	20
Retained Earnings	16.46	37.58	20.83	10.87	9.57
Total Common Equity	85.46	60.58	40.83	50.87	49.57
Shareholders' Equity	103.53	78.65	58.9	68.94	67.64
Total Liabilities & Equity	262.8	229.35	193.88	202.53	197.68
Total Debt	110.34	111.3	108.29	103.13	98.2
Net Cash (Debt)	-97.95	-103.4	-107.75	-101.72	-97.21
Net Cash Per Share	-14.20	-17.23	-17.96	-16.97	-16.14
Filing Date Shares Outstanding	6.9	6.9	6	6	6.02
Total Common Shares Outstanding	6.9	6.9	6	6	6.02
Working Capital	115.85	93.34	78.26	102.39	86.26
Book Value Per Share	12.39	8.78	6.81	8.48	8.23
Tangible Book Value	84.68	59.95	40.25	50.29	49.24
Tangible Book Value Per Share	12.27	8.69	6.71	8.38	8.17
Land	-	4.7	4.7	-	16.87
Machinery	21.92	20.55	14.6	-	4.53
Construction In Progress	-	4.48	-	-	-